
By Emma Weinbren (emmaweinbrenwrites@gmail.com)
Submissions deadline: 17 July 2026
Print, digital and sponsorship opportunities
Fmcg multinationals are throwing money behind supplements & wellbeing products. Take Unilever, which in April acquired US gummy supplement brand Grüns; or Suntory and Estrella Galicia, which put money behind Rem3dy Health in June. So, will the sector continue to prove profitable?
Investment: high-profile deals
- What have been the standout deals of the past 12 months?
- Why are multinationals so confident in the vitamins & supplements sector?
- Which brands are tipped for stratospheric growth?
Innovation: key trends
- Which ingredients and formats are proving most popular in vitamins & supplements?
- Which need states are behind the key trends?
- Is gut health still in growth?
Cold & flu: winter sniffles
- How are suppliers of OTC medicines preparing for cold & flu season?
- Which retailers are offering flu jabs and what’s the uptake been like?
- Is the way shoppers treat their colds changing?
Hayfever: allergies on the rise
- With allergies on the rise and longer pollen seasons, how are hayfever remedies faring?
- Which brands are outperforming the wider sector?
- What have been the standout innovations in this space?
Women’s health: periods, pregnancy & menopause
- How are retailers working to better support women’s health?
- Which brands are key disruptors in this space?
- Are prices over-inflated in this sector?
Innovation
- We will profile three new products or ranges. We need launch date, rsp, and a hi-res picture of each.
Downloads
FO Healthcare 2026
PDF, Size 0.22 mb






No comments yet